Tysabri and Maxalt-mlt drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Tysabri (natalizumab) and Maxalt-mlt (rizatriptan benzoate). Common drug interactions include progressive multifocal leukoencephalopathy among females and anticonvulsant drug level increased among males.
The phase IV clinical study analyzes what interactions people have when they take Tysabri and Maxalt-mlt. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.
What is Tysabri?
Tysabri has active ingredients of natalizumab. It is often used in multiple sclerosis. eHealthMe is studying from 221,369 Tysabri users. Check the latest studies of Tysabri.
What is Maxalt-mlt?
Maxalt-mlt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 1,534 Maxalt-mlt users. Check the latest studies of Maxalt-mlt.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
23 people who take Tysabri and Maxalt-mlt together, and have interactions are studied.

What are the common drug interactions of Tysabri and Maxalt-Mlt, by gender? *:
female:
- Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
- Fall
- Urinary tract infection
- Bladder dysfunction
- Blindness unilateral
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Nervous system disorder (a general class of medical conditions affecting the nervous system)
- Optic neuritis (optic nerve inflammation)
male:
- Anticonvulsant drug level increased
- Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
- Bladder dysfunction
- Fall
- Hyperbilirubinaemia (excess of bilirubin in the blood)
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)
- Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Urinary tract infection
What are the common drug interactions of Tysabri and Maxalt-Mlt, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Fall
- Bartholin's cyst (cyst is formed on one or both of the two bartholin's glands, which are located one on either side of the opening of the vagina)
- Feeling hot
- Ovarian cyst (fluid filled sac of the ovary)
- Pelvic haematoma (collection of blood outside of a blood vessel in pelvic region)
- Post procedural haemorrhage (post procedural bleeding)
- Postictal state
- Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
- Pyrexia (fever)
50-59:
- Fall
- Urinary tract infection
- Bladder dysfunction
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Opportunistic infection (a microorganism that normally does not cause disease but becomes pathogenic when the body's immune system is impaired and unable to fight)
- Bladder disorder
- Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)
60+:
- Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
- Bladder dysfunction
- Fall
- Hyperbilirubinaemia (excess of bilirubin in the blood)
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)
- Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Urinary tract infection
What are the existing conditions these people have? *
- Pain: 13 people, 56.52%
- Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 10 people, 43.48%
- Stress And Anxiety: 9 people, 39.13%
- Sleep Disorder: 9 people, 39.13%
- Restless Leg Syndrome (a powerful urge to move your legs): 8 people, 34.78%
- Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 8 people, 34.78%
- Fibromyalgia (a long-term condition which causes pain all over the body): 8 people, 34.78%
- Depression: 8 people, 34.78%
- Cystitis Interstitial (unknown cause characterized by bladder pain): 8 people, 34.78%
- Headache (pain in head): 6 people, 26.09%
* Approximation only. Some reports may have incomplete information.
Do you take Tysabri and Maxalt-mlt?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Tysabri (221,369 reports)
- Maxalt-mlt (1,534 reports)
Browse all drug interactions of Tysabri and Maxalt-mlt:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tysabri:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Maxalt-mlt:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tysabri and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Maxalt-mlt and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on natalizumab and rizatriptan benzoate (the active ingredients of Tysabri and Maxalt-mlt, respectively), and Tysabri and Maxalt-mlt (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Thiamine cause Respiratory Tract Congestion? - a second ago
- Could Zegerid cause Hypotension? - 4 seconds ago
- Drug interactions of Prednisone and Lipitor - 4 seconds ago
- Could Cymbalta cause Endometrial Cancer? - 7 seconds ago
- Could Mounjaro cause Tinnitus Aggravated? - 8 seconds ago
- Drug interactions of Tolvaptan and Coreg - 8 seconds ago
- Drug interactions of Fasenra and Hydrochlorothiazide - 12 seconds ago
- Could Zantac cause Impaired Driving Ability? - 13 seconds ago
- Could Zantac cause Blood Phosphorus Increased? - 17 seconds ago
- Could Ibrance cause Rhabdomyolysis? - 18 seconds ago